• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Prostate Cancer Drug Pathway Analyzer 2014 Product Image

Prostate Cancer Drug Pathway Analyzer 2014

  • Published: March 2014
  • Region: Global
  • Bioseeker

Extra value: One year of free online updates included with this product

There are today at least 386 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways for the treatment of prostate cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 261 drug targets that are included in this drug-pathway analyzing tool. No less than 255 of these have been recorded with mutations and 46 drug targets have mutations which have been causally implicated in cancer.

Pathway Coverage
- BioCarta# 244 Pathways
- KEGG# 189 Pathways
- NCI-Nature# 244 Pathways
- NetPath# 32 Pathways

Pipeline Coverage
Marketed# 30
Pre-registration# 2
Phase III# 20
Phase II# 157
Phase I# 80
Preclinical# 121
No Data# 4
Suspended# 5
Ceased# 191

The continuous identification of drug targets and pathways that are altered in cancer is not only crucial for our understanding of cancer biology, but also to search for new targets for early diagnosis and improved treatment designs. Consequently, it has never before been as important to rapidly translate systems biology READ MORE >



Delivery Format: Desktop App plus Online Access to Updates (One Year)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos